InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Hohe Gewinnwachstumsrate
Das Nettoeinkommen des Unternehmens führt die Branche an, das letzte Jahres Einkommen betrug insgesamt 143.44M USD.
Unterbewertet
Die aktuelle PE1 des Unternehmens liegt bei 26.472, im niedrigen 3-Jahres-Perzentilbereich.
Institutionelle Verkäufe
Die neuesten institutionellen Bestände sind 16.62M Aktien, was einen Rückgang von 11.38% im Vergleich zum Vorquartal darstellt.
Gehalten von ETHSX
Star-Investor ETHSX1 hält 1.28K2 Aktien dieses Unternehmens.
Höhere Marktaktivität
Das Unternehmen hat mehr Interesse von Investoren, mit einem 20-Tage-Umsatzverhältnis von 0.81.